Lexington Biomedical, Inc. — Form C-U (Regulation Crowdfunding)
Lexington Biomedical, Inc. of CAMBRIDGE, MA filed a Form C-U (Regulation Crowdfunding) with the SEC on 2025-04-21. Target raise $124K, up to $1.2M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2025-04-21
- Form: C-U
- Accession: 0001665160-25-000729
- Target amount: $124K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 100,813
- Price: $1.2300
- Deadline: 2025-04-30
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0002057514
- Website: http://biowearlife.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2013-09-26
- Address: 770 MASSACHUSETTS AVE, CAMBRIDGE, MA, 02139
- Employees: 2
Financials (as filed)
- Total assets (most recent): $57K
- Cash (most recent): $19K
- Net income (most recent): $-304K
- Net income (prior): $-287K
- Short-term debt: $387K
- Long-term debt: $1.1M
People (5)
| Name | Role | Location |
|---|
| Robert Frank | Co-Founder and Chief Cardiology Officer | Albuquerque, NM |
| Philippe Pierre Sauvage | Chief Strategy Advisor Post Funding, Board Member | CAMBRIDGE, MA |
| Jean Manuel Sobarzo | Founder, CEO, and Chairman of the Board | CAMBRIDGE, MA |
| David T. Martin | Board Member and Chief Cardiology Advisor | CAMBRIDGE, MA |
| W. Scott Hoge | Board Member, Director of Science and Chief Technology Officer | CAMBRIDGE, MA |
Reg CF filing history (2)
More